Patients ’ first-year adherence to different anti-osteoporotic therapy after hip fractures

The main clinical predictor for osteoporotic fracture is a history of a prior fracture. According to current evidence, one out of ten fracture patients with osteoporosis does not sustain another fracture if he or she is on adequatemedication[1-3]. The incidence of hip fracture has been increasing over time in global populations and hip fracture patients are at high risk of subsequent osteoporotic fractures [4]. Therefore, anti-osteoporosis medication after hip fracture is widely recommended by clinical practice guidelines and medication adherence is essential to maintain bone strength for most patients [5].
Source: Injury - Category: Orthopaedics Authors: Source Type: research